GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,775.00p
   
  • Change Today:
    -8.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 9,685,447
  • Market Cap: £73,572m
  • RiskGrade: 129

ShareCast News

GSK 'sticks two fingers up' as workers vote for ... 19-Apr-2023 ShareCast
GSK to buy Canada's Bellus Health for $2bn 18-Apr-2023 ShareCast
GSK announces positive results from trials of ne... 17-Apr-2023 ShareCast
GSK receives 'positive' results from endometrial... 28-Mar-2023 ShareCast
GSK disagrees with ranitidine evidence ruling in... 24-Mar-2023 ShareCast
Deutsche Bank upgrades GSK to 'buy' 17-Mar-2023 ShareCast
GSK upbeat on meningitis vaccine candidate, asth... 14-Mar-2023 ShareCast
GSK's ViiV says trial indicates HIV shot as effe... 23-Feb-2023 ShareCast
Berenberg raises target price on GSK 10-Feb-2023 ShareCast
GSK's endometrial cancer treatment receives full... 10-Feb-2023 ShareCast
FDA approves GSK anaemia drug 02-Feb-2023 ShareCast
Record vaccine sales boost profits at GSK 01-Feb-2023 ShareCast
GSK plans return of HQ to central London in 2024 12-Dec-2022 ShareCast
GSK shares jump as court dismisses Zantac claims 07-Dec-2022 ShareCast
EU validates market application for GSK blood ca... 02-Dec-2022 ShareCast
GSK cancer treatment meets trial endpoint 02-Dec-2022 ShareCast
ShoreCap stays at 'buy' for GSK, points to signi... 22-Nov-2022 ShareCast
GSK starts moves to pull FDA approval for blood ... 22-Nov-2022 ShareCast
Second-line use of GSK cancer drug restricted 11-Nov-2022 ShareCast
GSK's Blenrep fails to meet primary endpoint in ... 07-Nov-2022 ShareCast
GSK halts antibiotic trials early 03-Nov-2022 ShareCast
GSK lifts guidance as vaccines help Q3 beat expe... 02-Nov-2022 ShareCast
GSK rises as EMA gives nod to RSV, HIV candidates 28-Oct-2022 ShareCast
GSK abandons regulatory submissions of rheumatoi... 27-Oct-2022 ShareCast
GSK seeks Japanese approval for respiratory dise... 21-Oct-2022 ShareCast
GlaxoSmithKline receives FDA approval for new pr... 17-Oct-2022 ShareCast
GSK reports 'exceptional' result from respirator... 13-Oct-2022 ShareCast
US green lights GSK vaccine for use during pregn... 10-Oct-2022 ShareCast
GSK looks to Burberry for new CFO 26-Sep-2022 ShareCast
GSK takes stake in Spero in deal on UTI treatment 22-Sep-2022 ShareCast
Credit Suisse upgrades GSK, downgrades AstraZeneca 15-Sep-2022 ShareCast
Citi puts GSK on 'positive catalyst watch', cite... 26-Aug-2022 ShareCast
GSK application for myelofibrosis drug accepted ... 17-Aug-2022 ShareCast
Plaintiff in GSK Zantac lawsuit pulls suit for now 17-Aug-2022 ShareCast
GSK to 'vigorously defend' Zantac claims; Haleon... 12-Aug-2022 ShareCast
GSK, Haleon, Sanofi slump amid Zantac litigation... 11-Aug-2022 ShareCast
GSK lifts full-year outlook as Q2 sales rise 27-Jul-2022 ShareCast
Citi starts GSK spinoff Haleon at 'buy' 21-Jul-2022 ShareCast
GSK spins off consumer healthcare giant Haleon 18-Jul-2022 ShareCast
Covid-19 cases surge during latest week due to B... 01-Jul-2022 ShareCast
GSK submits shingles vaccine application in Japa... 28-Jun-2022 ShareCast
GlaxoSmithKline to invest £1bn in infectious dis... 23-Jun-2022 ShareCast
GSK says respiratory vaccine shows 'significant'... 10-Jun-2022 ShareCast
GSK's MMR vaccine Priorix gets US FDA approval 06-Jun-2022 ShareCast
GlaxoSmithKline to buy US biotech Affinivax in $... 31-May-2022 ShareCast
GlaxoSmithKline nears deal to build £400m scienc... 30-May-2022 ShareCast
China approves two-dose schedule for GSK's cervi... 27-May-2022 ShareCast
GSK sales top forecasts 27-Apr-2022 ShareCast
US FDA accepts GSK application for kidney diseas... 19-Apr-2022 ShareCast
GSK agrees to buy Sierra Oncology for $1.9bn 13-Apr-2022 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,775.00p
Change Today -8.50p
% Change -0.48 %
52 Week High 1,812.50p
52 Week Low 1,316.00p
Volume 9,685,447
Shares Issued 4,144.92m
Market Cap £73,572m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.05% below the market average69.05% below the market average69.05% below the market average69.05% below the market average69.05% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
47.89% above the market average47.89% above the market average47.89% above the market average47.89% above the market average47.89% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Income
2.90% above the market average2.90% above the market average2.90% above the market average2.90% above the market average2.90% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
20.71% below the market average20.71% below the market average20.71% below the market average20.71% below the market average20.71% below the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 17-May-2024

Time Volume / Share Price
16:51 423 @ 1,775.00p
16:37 20,200 @ 1,771.97p
16:36 10,580 @ 1,775.00p
16:35 3,357,820 @ 1,775.00p
16:35 2,092 @ 1,775.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page